UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

The role of hypoxia in erectile dysfunction mechanisms

International journal of impotence research, 2007-10, Vol.19 (5), p.496-500

2007

Link zum Volltext

Verfügbarkeit prüfen

Pampiniform Plexus and Oxidative Stress during Chronic Hypoxia and Hyperoxia

International journal of immunopathology and pharmacology, 2008-04, Vol.21 (2), p.353-357

2008

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of celecoxib and infusional 5‐fluorouracil as second‐line treatment for advanced pancreatic carcinoma

Cancer, 2004-07, Vol.101 (1), p.133-138

2004

Link zum Volltext

Verfügbarkeit prüfen

HPV genotypes concordance between sex partners

Journal of experimental & clinical cancer research, 2007-12, Vol.26 (4), p.609-612

2007

Link zum Volltext

Verfügbarkeit prüfen

Fixed dose‐rate gemcitabine infusion as first‐line treatment for advanced‐stage carcinoma of the pancreas and biliary tree

Cancer, 2005-09, Vol.104 (6), p.1237-1245

2005

Link zum Volltext

Verfügbarkeit prüfen

The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study

Journal of experimental & clinical cancer research, 2004-03, Vol.23 (1), p.25

2004

Link zum Volltext

Verfügbarkeit prüfen

Activity and tolerability of mitomycin-C (MMC) and chronomodulated capecitabine (C) in advanced colorecatal cancer (ACC) patients

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13563-13563

2006

Link zum Volltext

Verfügbarkeit prüfen

P-467 Chemotherapy with an every-2-week regimen of gemcitabine (G) and paGitaxel (P) followed by maintenance weekly paGitaxel in elderly patients with stage IIIB or IV in non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S239-S239

2005

Link zum Volltext

Verfügbarkeit prüfen

Exploratory phase II study of celecoxib and infusional fluorouracil as second-line treatment for advanced pancreatic (PDAC) and biliary tree cancer (BTC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4183-4183

2004

Link zum Volltext

Verfügbarkeit prüfen

Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4182-4182

2004

Link zum Volltext

Verfügbarkeit prüfen

Exploratory phase II study of celecoxib and infusional fluorouracil as second-line treatment for advanced pancreatic (PDAC) and biliary tree cancer (BTC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4183-4183

2004

Link zum Volltext

Verfügbarkeit prüfen

Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4182-4182

2004

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of the DNA Damage Response by Transforming Growth Factor-Beta Inhibitors Enhances Radiation Sensitivity of Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo

International journal of radiation oncology, biology, physics, 2015, Vol.91 (1), p.91-99

2015

Link zum Volltext

Verfügbarkeit prüfen

The microbiome and immunodeficiencies: Lessons from rare diseases

Journal of autoimmunity, 2019-03, Vol.98, p.132-148

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemo4MetPanc: A phase II study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment naïve pancreas adenocarcinoma (PDAC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.TPS454-TPS454

2021

Link zum Volltext

Verfügbarkeit prüfen

CheMo4METPANC: A phase 2 study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment-naïve pancreas adenocarcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4200-TPS4200

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Clinical cancer research, 2021-10, Vol.27 (20), p.5519-5527

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

AIDS (London), 2011-01, Vol.25 (2), p.177-183

2011

Link zum Volltext

Verfügbarkeit prüfen

Biologically Augmented Radiation Therapy via TGFβ Control of the Tumor Microenvironment

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S56-S56

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR-001: Ex vivo co-culture system with patient-derived organoids to assess CXCR4 inhibitor as an immune modulating agent for human pancreas adenocarcinoma

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (22_Supplement), p.PR-001-PR-001

2021

Link zum Volltext

Verfügbarkeit prüfen

Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment

Cancer immunology research, 2019-02, Vol.7 (2), p.306-320

2019

Link zum Volltext

Verfügbarkeit prüfen

Biologically Augmenting Radiation Therapy by Inhibiting TGFβ in NSCLC from Molecular to Microenvironment

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S139-S140

2013

Link zum Volltext

Verfügbarkeit prüfen

Concomitant Radiation Therapy and TGFβ Neutralizing Antibodies Alters Tumor Microenvironment and Promotes Tumor Regression

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S140-S140

2013

Link zum Volltext

Verfügbarkeit prüfen

Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes: A cross-sectional observational study from the AMD Annals initiative

Diabetes care, 2013-10, Vol.36 (10), p.3162-3168

2013

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.7764-7772

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Humans
(26)
Life Sciences & Biomedicine
(26)
Male
(16)
Female
(15)
Biological And Medical Sciences
(10)
Adult
(9)
Oncology
(9)
Endocrinology & Metabolism
(7)
Medical Sciences
(7)
Middle Aged
(6)
Animals
(5)
Immunology
(5)
Prolactin - Blood
(5)
Aged
(4)
Hematology, Oncology And Palliative Medicine
(4)
Radiology
(4)
Tumors
(4)
Cells, Cultured
(3)
Dendritic Cells - Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of hypoxia in erectile dysfunction mechanisms

Pampiniform Plexus and Oxidative Stress during Chronic Hypoxia and Hyperoxia

Pilot study of celecoxib and infusional 5‐fluorouracil as second‐line treatment for advanced pancreatic carcinoma

HPV genotypes concordance between sex partners

Fixed dose‐rate gemcitabine infusion as first‐line treatment for advanced‐stage carcinoma of the pancreas and biliary tree

The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study

Activity and tolerability of mitomycin-C (MMC) and chronomodulated capecitabine (C) in advanced colorecatal cancer (ACC) patients

P-467 Chemotherapy with an every-2-week regimen of gemcitabine (G) and paGitaxel (P) followed by maintenance weekly paGitaxel in elderly patients with stage IIIB or IV in non-small cell lung cancer (NSCLC)

Exploratory phase II study of celecoxib and infusional fluorouracil as second-line treatment for advanced pancreatic (PDAC) and biliary tree cancer (BTC)

Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study

Exploratory phase II study of celecoxib and infusional fluorouracil as second-line treatment for advanced pancreatic (PDAC) and biliary tree cancer (BTC)

Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study

Attenuation of the DNA Damage Response by Transforming Growth Factor-Beta Inhibitors Enhances Radiation Sensitivity of Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo

The microbiome and immunodeficiencies: Lessons from rare diseases

Chemo4MetPanc: A phase II study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment naïve pancreas adenocarcinoma (PDAC)

CheMo4METPANC: A phase 2 study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment-naïve pancreas adenocarcinoma

A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

Biologically Augmented Radiation Therapy via TGFβ Control of the Tumor Microenvironment

Abstract PR-001: Ex vivo co-culture system with patient-derived organoids to assess CXCR4 inhibitor as an immune modulating agent for human pancreas adenocarcinoma

Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment

Biologically Augmenting Radiation Therapy by Inhibiting TGFβ in NSCLC from Molecular to Microenvironment

Concomitant Radiation Therapy and TGFβ Neutralizing Antibodies Alters Tumor Microenvironment and Promotes Tumor Regression

Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes: A cross-sectional observational study from the AMD Annals initiative

Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells

Suchergebnisse filtern